Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lundbeck
Marketing
Lundbeck hit with untitled letter over Vyepti efficacy claims
The FDA took issue with multiple claims describing Vyepti's efficacy listed on Lundbeck's healthcare provider webpage for the drug.
Zoey Becker
Jul 8, 2026 4:23pm
Axsome increases Auvelity's peak sales projection to $8B
May 5, 2026 11:48am
Axsome's Auvelity wins FDA expansion for Alzheimer's agitation
May 1, 2026 11:42am
Trump admin rolls out 15 high-profile drugs for IRA price cuts
Jan 27, 2026 5:44pm
After Avadel setback, Lundbeck signals future M&A rigor
Jan 22, 2026 11:13am
Rising Stars: Andrew Willett on bettering the world via comms
Dec 17, 2025 6:00am
